Answer
Inotuzumab ozogamicin can harm an unborn baby based on non-clinical findings, although there are no data in pregnant women, and must not be used during pregnancy unless the potential benefit to the mother outweighs the potential risks to the foetus.
Sources for this answer
- BESPONSA 1 mg powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked